| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.31▲ | 2.34▼ | 2.34▼ | 2.49▼ | 2.28▲ |
| MA10 | 2.40▼ | 2.44▼ | 2.44▼ | 2.53▼ | 1.88▲ |
| MA20 | 2.46▼ | 2.50▼ | 2.51▼ | 2.32▼ | 1.74▲ |
| MA50 | 2.56▼ | 2.57▼ | 2.57▼ | 1.85▲ | 3.23▼ |
| MA100 | 2.59▼ | 2.47▼ | 2.32▼ | 1.72▲ | N/A |
| MA200 | 2.39▼ | 2.05▲ | 1.91▲ | 2.72▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.021▼ | -0.028▼ | -0.032▼ | -0.027▼ | 0.217▲ |
| RSI | 32.695▼ | 34.009▼ | 35.233▼ | 53.518▲ | 51.386▲ |
| STOCH | 2.091▼ | 13.866▼ | 13.866▼ | 49.877 | 84.606▲ |
| WILL %R | -91.803▼ | -91.803▼ | -91.803▼ | -66.662 | -31.784 |
| CCI | -82.899 | -128.586▼ | -128.787▼ | -74.290 | 135.808▲ |
|
Tuesday, September 01, 2026 03:02 PM
Dogwood Therapeutics (NASDAQ:DWTX) said its Phase 2b study of Halneuron, an investigational treatment for chemotherapy-induced neuropathic pain, has enrolled more than 230 patients and is expected to ...
|
|
Thursday, August 13, 2026 01:30 AM
Halneuron®Phase 2b trial in Chemotherapy Induced Neuropathy on track for top-line results in fall 2026, 217 patients enrolled –- Commencement ...
|
|
Tuesday, June 30, 2026 05:45 AM
ALPHARETTA, Ga., June 30, 2026 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a company that focuses on developing first-in-class, new non-opioid medicines ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/09/26 | 2.36 | 2.37 | 2.285 | 2.31 | 69,720 |
| 03/09/26 | 2.50 | 2.59 | 2.47 | 2.47 | 18,019 |
| 02/09/26 | 2.60 | 2.66 | 2.45 | 2.48 | 50,400 |
| 01/09/26 | 2.70 | 2.725 | 2.56 | 2.63 | 145,135 |
| 31/08/26 | 2.61 | 2.74 | 2.5352 | 2.58 | 64,152 |
| 28/08/26 | 2.36 | 2.69 | 2.36 | 2.65 | 133,665 |
| 27/08/26 | 2.64 | 2.64 | 2.32 | 2.32 | 67,209 |
| 26/08/26 | 2.70 | 2.7899 | 2.60 | 2.66 | 120,552 |
| 25/08/26 | 2.64 | 2.68 | 2.53 | 2.68 | 122,411 |
| 24/08/26 | 2.65 | 2.67 | 2.53 | 2.545 | 95,709 |
|
|
||||
|
|
||||
|
|